<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Silver nitrate: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Silver nitrate: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Silver nitrate: Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="12118" href="/d/html/12118.html" rel="external">see "Silver nitrate: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12788" href="/d/html/12788.html" rel="external">see "Silver nitrate: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F221080"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antibiotic, Topical;</li>
<li>
                        Cauterizing Agent, Topical;</li>
<li>
                        Topical Skin Product, Antibacterial</li></ul></div>
<div class="block doa drugH1Div" id="F221068"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="25293193-5063-4eb8-9742-30773a2654fb">Anti-infective</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Anti-infective (0.5% solution):</b>
<b>Topical:</b> Use as directed.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="fa8432aa-49cf-401c-aa3d-c7518ec6192c">Granulation tissue removal, wound cauterization</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Granulation tissue removal, wound cauterization: Topical:</b> Sticks: Apply to affected area; application may be repeated every 24 hours for a total of 3 applications for granulation tissue (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-2279350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-2279350'])">Ref</a></span>) or once weekly (over several weeks if needed) for pyogenic granuloma (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-12772100']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-12772100'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block doe drugH1Div" id="F221069"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F221076"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12788" href="/d/html/12788.html" rel="external">see "Silver nitrate: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="fc590d40-daf5-4868-bdbe-32b30088ad6d">Antiseptic, wound cauterization, degranulation of tissue</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Antiseptic, wound cauterization, degranulation of tissue (warts, corns): Note:</b> Specific application techniques, frequency, and duration may vary with specific use (eg, warts vs burns); refer to institutional protocols.</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-17269982','lexi-content-ref-22972052','lexi-content-ref-3190284']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-17269982','lexi-content-ref-22972052','lexi-content-ref-3190284'])">Ref</a></span>): Topical:</p>
<p style="text-indent:-2em;margin-left:6em;">Sticks: Apply to mucous membranes and other moist skin surfaces only on area to be treated</p>
<p style="text-indent:-2em;margin-left:6em;">Topical solution: Apply a cotton applicator dipped in solution on the affected area 2 to 3 times/week for 2 to 3 weeks</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F221048"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Burning sensation of skin, skin discoloration, skin irritation</p>
<p style="text-indent:-2em;margin-left:2em;">Hematologic &amp; oncologic: Methemoglobinemia</p></div>
<div class="block coi drugH1Div" id="F221060"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">There are no contraindications listed in the manufacturer’s labeling.</p></div>
<div class="block war drugH1Div" id="F221045"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Chemical burn: Silver nitrate is a caustic agent and inappropriate use may cause chemical burns. Skin contact time with applicator sticks should be extremely short when used in neonates or on thin delicate skin. Wear chemical-resistant gloves and other appropriate personal protective equipment while using this product. Take care to confine the silver nitrate to the area being treated by using an appropriate physical or chemical barrier to prevent staining or burning of untreated tissue.</p>
<p style="text-indent:-2em;margin-left:4em;">• Skin discoloration: Prolonged use may result in skin discoloration. Silver salts stain tissue black due to deposition of reduced silver. The stain gradually disappears within a period of 2 weeks. Prolonged ingestion or absorption of silver compounds leads to deposition of silver in connective tissues, producing a slate-blue discoloration of the skin known as argyria. This discoloration may also appear on mucous membranes, such as the margins of gums. The sclera of the eye is also stained.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Do not use applicator sticks on the eyes. Do not use topical solution on mucous membranes.</p></div>
<div class="block foc drugH1Div" id="F221055"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Applicator sticks, topical: Silver nitrate 75% and potassium nitrate 25%</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, topical: 0.5% (960 mL); 10% (30 mL); 25% (30 mL); 50% (30 mL)</p></div>
<div class="block geq drugH1Div" id="F221041"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16323840"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Misc</b> (Arzol Silver Nit Applicators External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">75-25% (per each): $0.84</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Silver Nitrate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.5% (per mL): $0.10</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F221057"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Topical:</b> Applicator sticks are <b>not</b> for ophthalmic use. If applicator sticks are used on dry skin, dip the applicator tip in distilled, deionized, or purified water immediately before use and apply by holding, rubbing, or rotating the tip along the affected tissue. One silver nitrate applicator is generally sufficient for each application. The action of the silver nitrate can be stopped by washing the area with saline solution (0.9% sodium chloride). Using saline solution to wet the applicator tips, or residual saline from wound flushing/washing, will interfere with the action of silver nitrate resulting in cauterization failure. Only use distilled, deionized, or purified water to wet applicator tips. Blot dry wounds that have been flushed/washed with saline prior to applying silver nitrate. Apply to mucous membranes and other moist skin surfaces only on area to be treated.</p></div>
<div class="block admp drugH1Div" id="F52613853"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">For topical use only. Applicators are <b>not</b> for ophthalmic use. If applicator sticks are used on dry skin, dip the applicator tip in water immediately before use. Applicator sticks may be bent or shaped for easier access to target area.</p></div>
<div class="block use drugH1Div" id="F221056"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Anti-infective (0.5% solution):</b> Used as a topical anti-infective agent.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Cauterization of skin or mucous membrane; removal of warts and granulated tissue (applicator sticks):</b> Apply to the skin for cauterization of wounds and for removal of granulation tissue and warts. On mucous membranes, may be applied to small ulcers and aphthae in the mouth resulting from injury or stomatitis, to infected tonsils, to rectal fissures and fistulae, and to vaginal or cervical ulcerations or erosions.</p></div>
<div class="block cyt drugH1Div" id="F13300040"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6222926"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Cellulose (Oxidized Regenerated): Silver Nitrate may diminish the therapeutic effect of Cellulose (Oxidized Regenerated). <i> Risk X: Avoid combination</i></p></div>
<div class="block pha drugH1Div" id="F221044"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Free silver ions precipitate bacterial proteins by combining with chloride in tissue forming silver chloride; coagulates cellular protein to form an eschar; silver ions or salts or colloidal silver preparations can inhibit the growth of both gram-positive and gram-negative bacteria. This germicidal action is attributed to the precipitation of bacterial proteins by liberated silver ions. Silver nitrate coagulates cellular protein to form an eschar, and this mode of action is the postulated mechanism for control of benign hematuria, rhinitis, and recurrent pneumothorax.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F6038828"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Nitrato de prata</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Argentrix | Hoellenstein</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Porgukivipulk</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Avoca caustic applicator</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Avoca caustic applicator</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Silver stream</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Silver nitrate pfizer</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Nitrato de Plata</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Avoca Caustic Applicator</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Argenti nitras | Lapis pencil | Stilus lapidis</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Arzol (75% silver nitrate/25% potassium nitrate) silver nitrate applicator [prescribing information]. Keene, NH: Arzol Chemical Co; January 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17269982">
<a name="17269982"></a>Ebrahimi S, Dabiri N, Jamshidnejad E, Sarkari B. Efficacy of 10% silver nitrate solution in the treatment of common warts: a placebo-controlled, randomized, clinical trial. <i>Int J Dermatol</i>. 2007;46(2):215-217.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/silver-nitrate-drug-information/abstract-text/17269982/pubmed" id="17269982" target="_blank">17269982</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Grafco.1">
<a name="Grafco.1"></a>Grafco (75% silver nitrate/25% potassium nitrate) silver nitrate applicator [prescribing information]. Atlanta, GA: GF Health Products Inc; received June 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22972052">
<a name="22972052"></a>Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. <i>Cochrane Database Syst Rev</i>. 2012;(9):CD001781.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/silver-nitrate-drug-information/abstract-text/22972052/pubmed" id="22972052" target="_blank">22972052</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2279350">
<a name="2279350"></a>McGrath J, Schofield O. Treatment of excessive granulation tissue with EMLA cream and 95% silver-nitrate pencils. <i>Clin Exp Dermatol</i>. 1990;15(6):468. doi:10.1111/j.1365-2230.1990.tb02152.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/silver-nitrate-drug-information/abstract-text/2279350/pubmed" id="2279350" target="_blank">2279350</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12772100">
<a name="12772100"></a>Quitkin HM, Rosenwasser MP, Strauch RJ. The efficacy of silver nitrate cauterization for pyogenic granuloma of the hand. <i>J Hand Surg Am</i>. 2003;28(3):435-438. doi:10.1053/jhsu.2003.50092<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/silver-nitrate-drug-information/abstract-text/12772100/pubmed" id="12772100" target="_blank">12772100</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Silver Nitrate solution [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA Inc; February 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3190284">
<a name="3190284"></a>Tompkins RG, Remensnyder JP, Burke JF, et al. Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. <i>Ann Surg</i>. 1988;208(5):577-585.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/silver-nitrate-drug-information/abstract-text/3190284/pubmed" id="3190284" target="_blank">3190284</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9888 Version 113.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
